NOUVEAUX COMPOSES UTILISES EN TANT QUE MODULATEURS ALLOSTERIQUES POSITIFS POUR L'ERYTHROPOIETINE ET LE RECEPTEUR DE L'ERYTHROPOIETINE POUR LE TRAITEMENT DE MALADIES LIEES A UNE DEFICIENCE EN ERYTHROPOIETINE
Disclosed are compounds which can act as a positive allosteric modulator for erythropoietin and erythropoietin receptor and have the activity in promoting erythropoiesis. Also disclosed are pharmaceutical compositions comprising said compounds and treatment methods utilizing said compounds.